Abstract
Isolated perfusion for regional chemotherapy is only practical for tumors located on the extremity, because this is the only site where adequate vascular occlusion can be achieved. Indications for perfusion in clinical stage I melanoma patients are determined by microstaging of the tumor. At our institution, patients with Clark's levels III, IV, or V and a Breslow thickness of ≥1.5 mm are eligible. Lower limb perfusions are started through an iliac perfusion. Two perfusions are performed for foot lesions, local recurrences, satellitosis, or intransit metastases.
Flow rates for leg perfusion vary from 600 to 1,000 ml/min. During the past few years, higher flows (up to about 1,200 ml/min) have been utilized. Less toxicity developed with better tissue perfusion, and the dosage of cytostatics could be increased. The dosage of cytostatic drugs is calculated by limb volume, as determined by immersion in water. In our opinion, hyperthermia yields superior results for cases of local recurrence or intransit métastases. It is not known if a combination of cytostatic drugs might improve results compared to a single drug.
Résumé
La chimiothérapie régionale par perfusion isolée ne s'applique qu'aux mélanomes malins situés au niveau des extrêmités car c'est le seul siège qui permet de réaliser une occlusion vasculaire satisfaisante. Les indications de la perfusion pour les malades porteurs d'une tumeur de stade clinique I sont déterminées par le stade microscopique de la tumeur. Pour les auteurs, les malades avec des lésions de type III, IV, V de Clark et une lésion d'une épaisseur de plus de 1.5 mm relèvent de ce traitement. Les perfusions du membre inférieur se font par voie iliaque; 2 sont pratiquées pour les lésions du pied, les récidives locales, les lésions satellites et les métastases.
Les taux du flux pour la perfusion de la jambe varient de 600 à 1,000 ml/mm. Au cours des dernières années, des flux plus importants (jusqu'à 1,200 ml/mm environ) avaient été utilisés. Une diminution de la toxicité grâce à une meilleure perfusion tissulaire et du dosage des cytostatiques pourrait être obtenue. La dose des agents cytostatiques à employer est calculée à partir du volume du membre déterminé par l'immersion de celui-ci dans l'eau. Selon l'opinion des auteurs, l'hyperthermie donne de meilleurs résultats en présence de récidive locale ou de métastases. Actuellement on ignore si une combinaison de drogues peut avoir une efficacité supérieure à une drogue unique.
Resumen
La perfusión aislada para quimioterapia regional sólo es de utilidad práctica para tumores localizados en una extremidad, porque ésta es la única ubicación donde se puede realizar oclusión vascular adecuada. Las indicaciones para perfusión en melanomas en estado clínico I son determinadas por la clasificación microscópica del estado del tumor. En nuestra institución los pacientes con melanomas de niveles III, IV, o V y un espesor de Breslow de ≥1.5 mm son elegibles. Las perfusiones de las extremidades inferiores son iniciadas a través de una perfusión iliaca. Se realizan 2 perfusiones para lesiones del pie, para recurrencias locales, satelosis, o metástasis en tránsito.
Los flujos para la perfusión de la pierna varían entre 600 y 1,000 ml/min. En el curso de los últimos años se han utilizado flujos mayores (hasta de 1,200 ml/min). Con la mejor perfusión se desarrolla menos toxicidad y la dosis de los agentes citotóxicos puede ser aumentada. La dosis de las drogas citotóxicas es calculada sobre el volumen de la extremidad determinado por inmersión en agua. En nuestra opinión la hipotermia da mejores resultados en casos de recurrencia local o de metástasis en tránsito. No se sabe si una combinación de drogas citostáticas puede dar mejores resultados que el uso de una droga única.
Similar content being viewed by others
References
Klopp, C., Alford, T., Bateman, J., Berry, G., Winship, T.: Fractionated intra-arterial cancer chemotherapy with methyl bisamine hydrochloride. A preliminary report. Ann. Surg.132:811, 1950
Creech, O., Ryan, R., Krementz, E.: Treatment of malignant melanoma by isolation perfusion technique. J.A.M.A.169:339, 1959
Stehlin, J., Clark, R., White, E.: Regional chemotherapy for cancer. Experiences with 116 perfusions. Ann. Surg.151:605, 1960
Luck, J.: Action of P-di(2-chloroethyl)-amino-L-phenylalanine on Harding Passey mouse melanoma. Science123:984, 1956
Cavaliere, R., Ciocatto, E., Giovanella, B., Heidelberger, C., Johnson, R., Margottini, M., Mondovi, B., Moricca, G., Rossi-Fanelli, A.: Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer20:1351, 1967
Aigner, K., Hild, P., Henneking, K., Paul, E., Hundeiker, M.: Regional perfusion with cis-platinum and dacarbazine. Recent Results Cancer Res.86:239, 1983
McBride, C., Smith, L., Brown, B.: Primary malignant melanoma of the limbs. A re-evaluation using microstaging techniques. Cancer48:1463, 1981
Illig, L., Aigner, K.: Therapie des malignen Melanoms unter besonderer Berüchsichtigung der isolierten Extremitätenperfusion. Dt Arztebl.77:2911, 1980
Jonsson, P., Hafstrom, L., Hugander, A.: Results of regional perfusion for primary and recurrent melanomas of the extremities. Recent Results Cancer Res.86:277, 1983
Krementz, E.T., Carter, R.D., Sutherland, C.M., Campbell, M.: The use of regional chemotherapy in the management of malignant melanoma. World J. Surg.3:289, 1979
Krementz, E., Campbell, M.: The role of limb perfusion in the management of malignant melanoma. In Malignant Melanoma, J. Constanzi, editor, The Hague, Martinus Nijhoff, 1983, pp. 224–257
Lejeune, F., Deloof, T., Ewalenko, P., Frühling, J., Jabri, M., Mathieu, M., Nogaret, J.-M., Verhest, A.: Objective regression of unexcised melanoma in-transit metastases after hyperthermic isolation perfusion of the limbs with melphalan. Recent Results Cancer Res.86:268, 1983
Martijn, H., Oldhoff, J., Oosterhuis, J.W., Schraffordt Koops, H.: Indications for elective groin dissection in clinical stage I patients with malignant melanoma of the lower extremity treated by hyperthermic regional perfusion. Cancer52:1526, 1983
Martijn, H., Oldhoff, J., Schraffordt Koops, H.: Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbs. Eur. J. Cancer70:471, 1981
Martijn, H., Oldhoff, J., Schraffordt Koops, H., Oosterhuis, J.W.: Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin-D in the treatment of locally metastasized malignant melanoma of the extremities. J. Surg. Oncol.20:9, 1982
Rochlin, D., Smart, C.: Treatment of malignant melanoma by regional perfusion. Cancer18:1544, 1965
Schraffordt Koops, H.: Prevention of neural and muscular lesions during hyperthermic regional perfusion. Surg. Gynecol. Obstet.135:401, 1972
Schraffordt Koops, H., Oldhoff, J., van der Ploeg, E., Vermey, A., Eibergen, R., Beekhuis, H.: Some aspects of the treatment of primary malignant melanoma of the extremities by isolated regional perfusion. Cancer39:27, 1977
Schraffordt Koops, H., Oldhoff, J., van der Ploeg, E., Vermey, A., Eibergen, R.: Regional perfusion for recurrent malignant melanoma of the extremities. Am. J. Surg.133:221, 1977
Schraffordt Koops, H., Beekhuis, H., Oldhoff, J., Oosterhuis, J.W., van der Ploeg, E., Vermey, A.: Local recurrence and survival in patients with (Clark's level IV/V and over 1.5 mm thickness) stage I malignant melanoma of the extremities after regional perfusion. Cancer48:1952, 1981
Shingleton, W.: Perfusion chemotherapy for recurrent melanoma of the extremity. A progress report. Ann. Surg.169:969, 1969
Stehlin, J.S., Jr., Giovanella, B.C., de Ipolyi, P.D., Anderson, R.F.: Eleven years' experience with hyperthermic perfusion for melanoma of the extremities. World J. Surg.3:305, 1979
Sugarbaker, E., McBride, C.: Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities. Cancer37:188, 1976
Tonak, J., Hohenberger, W., Weidner, F., Gohl, H.: Hyperthermic perfusion in malignant melanoma: 5-year results. Recent Results Cancer Res.86:229, 1983
Vaglini, M., Ammatuna, M., Nova, M., Prada, A., Rovini, D., Santiname, M., Cascinelli, N.: Regional perfusion at high temperature of stage IIIA–IIIAB melanoma patients. Tumori69:585, 1983
Fontijne, W., de Vries, J., Mook, P., Elstrodt, J., Oosterhuis, J.W., Schraffordt Koops, H., Oldhoff, J., Wildevuur, C.: Improved tissue perfusion during pressure-regulated hyperthermic regional isolated perfusion in dogs. J. Surg. Oncol.69:76, 1984
Wieberdink, J., Benckhuizen, C., Braat, R., van Slooten, E.A., Olthuis, G.: Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic reactions. Eur. J. Cancer Clin. Oncol.18:905, 1982
van Os, J., Schraffordt Koops, H., Oldhoff, J.: Dosimetry of cytostatics in hyperthermic regional isolated perfusion. Cancer55:698, 1985
Martijn, H., Schraffordt Koops, H., Milton, G.W., Nap, M., Oosterhuis, J.W., Shaw, H.M., Oldhoff, J.: Comparison of two methods of treating primary malignant melanomas Clark IV and V, thickness 1.5 mm and more, localized on the extremities, wide surgical excision with and without adjuvant regional perfusion. Cancer57:1923, 1986
Au, F., Goldman, L.: Isolation perfusion in limb melanoma: A critical assessment and literature review. In Human Malignant Melanoma, W.H. Clark, L.J. Goldman, M.L. Mastrangelo, New York, Grune & Stratton, 1979, pp. 295–308
EORTC Newsletter: Letter 110. Gisela Haemmerli, April, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koops, H.S., Oldhoff, J., Oosterhuis, J.W. et al. Isolated regional perfusion in malignant melanoma of the extremities. World J. Surg. 11, 527–533 (1987). https://doi.org/10.1007/BF01655819
Issue Date:
DOI: https://doi.org/10.1007/BF01655819